Peter Whitton - 31 Jul 2022 Form 5 Insider Report for Bakhu Holdings, Corp.

Role: Director, 10%+ Owner
Signature: Peter Whitton
Issuer symbol: BKUH on OTC
Transactions as of: 31 Jul 2022
Net transactions value: $0
Form type: 5
Filing time: 09 Aug 2022, 19:02:54 UTC
Previous filing: 01 Jun 2022
Next filing: 02 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Shares After	Date	Ownership	Footnotes
holding	BKUH	Common Stock	24,160,007	31 Jul 2022	Direct
holding	BKUH	Common Stock	6,000,000	31 Jul 2022	Mentone Ltd.	F1
holding	BKUH	Series A Preferred Stock	4	31 Jul 2022	Cell Science Holdings Ltd.	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	BKUH	Stock Option						100,000	31 Jul 2022	Common Stock	100,000	$5.10	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Mentone Ltd. is owned 34% by Peter Whitton, 33% Geoffrey Dixon and 33% by Karl Watkin, and therefore each of Messrs. Whitton, Dixon and Watkin are deemed to be the beneficial owners of the 6,000,000 shares of common stock owned of record by Mentone Ltd.
F2	Cell Science Holding Ltd., is the owner of 4 shares of Series A Preferred Stock. Cell Science is owned 40% by Inter-M Traders FZ LLE, 30% by the OZ Corporation and 30% by Mentone Ltd., all of whom are deemed to be the beneficial owners of the 4 shares of Series A Preferred Stock. Mentone Ltd. is owned 34% by Peter Whitton, 33% Geoffrey Dixon and 33% by Karl Watkin, and therefore each Mr. Whitton is deemed to be the beneficial owner of the 4 shares of Series A Preferred Stock.

Content

Mentone Ltd. is owned 34% by Peter Whitton, 33% Geoffrey Dixon and 33% by Karl Watkin, and therefore each of Messrs. Whitton, Dixon and Watkin are deemed to be the beneficial owners of the 6,000,000 shares of common stock owned of record by Mentone Ltd.

Cell Science Holding Ltd., is the owner of 4 shares of Series A Preferred Stock. Cell Science is owned 40% by Inter-M Traders FZ LLE, 30% by the OZ Corporation and 30% by Mentone Ltd., all of whom are deemed to be the beneficial owners of the 4 shares of Series A Preferred Stock. Mentone Ltd. is owned 34% by Peter Whitton, 33% Geoffrey Dixon and 33% by Karl Watkin, and therefore each Mr. Whitton is deemed to be the beneficial owner of the 4 shares of Series A Preferred Stock.